Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 89054832 | 8905483 | 2 | F | 20120129 | 20160916 | 20121109 | 20160921 | EXP | PHHY2012CA102025 | NOVARTIS | 51.25 | YR | F | Y | 0.00000 | 20160921 | CN | COUNTRY NOT SPECIFIED | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 89054832 | 8905483 | 1 | PS | GILENYA | FINGOLIMOD HYDROCHLORIDE | 1 | Oral | 0.5 MG | 20 | MG | Y | 22527 | .5 | MG | CAPSULE | QD | |||
| 89054832 | 8905483 | 2 | C | DITROPAN | OXYBUTYNIN CHLORIDE | 1 | Unknown | UNK | U | 0 | |||||||||
| 89054832 | 8905483 | 3 | C | IRBESARTAN. | IRBESARTAN | 1 | Unknown | UNK | U | 0 | |||||||||
| 89054832 | 8905483 | 4 | C | CELEBREX | CELECOXIB | 1 | Unknown | UNK | U | 0 | |||||||||
| 89054832 | 8905483 | 5 | C | SYNTHROID | LEVOTHYROXINE SODIUM | 1 | Unknown | UNK | U | 0 | |||||||||
| 89054832 | 8905483 | 6 | C | VITAMIN D | CHOLECALCIFEROL | 1 | Unknown | UNK | U | 0 | |||||||||
| 89054832 | 8905483 | 7 | C | DILAUDID | HYDROMORPHONE HYDROCHLORIDE | 1 | Unknown | UNK | U | 0 | |||||||||
| 89054832 | 8905483 | 8 | C | HYDROMORPHONE | HYDROMORPHONE | 1 | Unknown | UNK | U | 0 | |||||||||
| 89054832 | 8905483 | 9 | C | FOSAMAX | ALENDRONATE SODIUM | 1 | Unknown | UNK | U | 0 | |||||||||
| 89054832 | 8905483 | 10 | C | OXYBUTYNIN | OXYBUTYNIN | 1 | Unknown | UNK | U | 0 | |||||||||
| 89054832 | 8905483 | 11 | C | ALENDRONATE SODIUM. | ALENDRONATE SODIUM | 1 | Unknown | UNK | U | 0 | |||||||||
| 89054832 | 8905483 | 12 | C | CALCIUM | CALCIUM | 1 | Unknown | UNK | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 89054832 | 8905483 | 1 | Relapsing-remitting multiple sclerosis |
| 89054832 | 8905483 | 2 | Product used for unknown indication |
| 89054832 | 8905483 | 3 | Product used for unknown indication |
| 89054832 | 8905483 | 4 | Product used for unknown indication |
| 89054832 | 8905483 | 5 | Product used for unknown indication |
| 89054832 | 8905483 | 6 | Product used for unknown indication |
| 89054832 | 8905483 | 7 | Product used for unknown indication |
| 89054832 | 8905483 | 8 | Product used for unknown indication |
| 89054832 | 8905483 | 9 | Product used for unknown indication |
| 89054832 | 8905483 | 10 | Product used for unknown indication |
| 89054832 | 8905483 | 11 | Product used for unknown indication |
| 89054832 | 8905483 | 12 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 89054832 | 8905483 | LT |
| 89054832 | 8905483 | DS |
| 89054832 | 8905483 | HO |
| 89054832 | 8905483 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 89054832 | 8905483 | Blood magnesium decreased | |
| 89054832 | 8905483 | CSF protein increased | |
| 89054832 | 8905483 | Central nervous system lesion | |
| 89054832 | 8905483 | Generalised tonic-clonic seizure | |
| 89054832 | 8905483 | Hemiparesis | |
| 89054832 | 8905483 | Hepatic enzyme increased | |
| 89054832 | 8905483 | Loss of consciousness | |
| 89054832 | 8905483 | Muscle rigidity |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 89054832 | 8905483 | 1 | 20111220 | 20120129 | 0 |